Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-19

FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)

View source ↗

Summary

FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)